These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23558285)
1. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells. Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285 [TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Krishnamurthy S; Dong Z; Vodopyanov D; Imai A; Helman JI; Prince ME; Wicha MS; Nör JE Cancer Res; 2010 Dec; 70(23):9969-78. PubMed ID: 21098716 [TBL] [Abstract][Full Text] [Related]
3. In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status. Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E PLoS One; 2017; 12(10):e0186186. PubMed ID: 29028842 [TBL] [Abstract][Full Text] [Related]
4. Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells. Desiderio V; Papagerakis P; Tirino V; Zheng L; Matossian M; Prince ME; Paino F; Mele L; Papaccio F; Montella R; Papaccio G; Papagerakis S Oncotarget; 2015 Jan; 6(1):71-84. PubMed ID: 25428916 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
7. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links. Wenzel CT; Scher RL; Richtsmeier WJ Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1279-86. PubMed ID: 7576475 [TBL] [Abstract][Full Text] [Related]
8. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333 [TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma. Chinn SB; Darr OA; Owen JH; Bellile E; McHugh JB; Spector ME; Papagerakis SM; Chepeha DB; Bradford CR; Carey TE; Prince ME Head Neck; 2015 Mar; 37(3):317-26. PubMed ID: 24415402 [TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877 [TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915 [TBL] [Abstract][Full Text] [Related]
12. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Farmer RW; Richtsmeier WJ; Scher RL Head Neck; 1998 Dec; 20(8):726-31. PubMed ID: 9790295 [TBL] [Abstract][Full Text] [Related]
13. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Campos MS; Neiva KG; Meyers KA; Krishnamurthy S; Nör JE Oral Oncol; 2012 Jan; 48(1):26-32. PubMed ID: 22014666 [TBL] [Abstract][Full Text] [Related]
14. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025 [TBL] [Abstract][Full Text] [Related]
16. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties. Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460 [TBL] [Abstract][Full Text] [Related]
17. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875 [TBL] [Abstract][Full Text] [Related]
18. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016 [TBL] [Abstract][Full Text] [Related]